+86 531 68657995
sales@bosschemical.com
Tadalafil
171596-29-5-COA 171596-29-5-MSDS
| Tadalafil Basic information | |
| Indications and uses Clinical Research Side effects Warnings and precautions | |
| Product Name: | Tadalafil |
| Synonyms: | TADALAFIL;CIALIS;IC 351;(6R,12AR)-6-(benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1′,2′:1,6]pyrido;GF 196960;ICOS 351;Tildenafil;UK 336017 |
| CAS: | 171596-29-5 |
| MF: | C22H19N3O4 |
| MW: | 389.4 |
| EINECS: | 687-782-2 |
| Product Categories: | 11;Steroid and Hormone;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;API’s;Active Pharmaceutical Ingredients;Cnbio;Erectile Dysfunction;Inhibitor;API;Tadalafil;NUCYNTA;Pyridines ,Halogenated Heterocycles |
| Mol File: | 171596-29-5.mol |
| Tadalafil Chemical Properties | |
| Melting point | 298-300°C |
| alpha | D20 +71.0° |
| Boiling point | 679.1±55.0 °C(Predicted) |
| density | 1.51±0.1 g/cm3(Predicted) |
| Fp | 2℃ |
| storage temp. | Sealed in dry,2-8°C |
| solubility | DMSO: soluble20mg/mL, clear |
| pka | 16.68±0.40(Predicted) |
| form | powder |
| color | white to beige |
| optical activity | [α]/D +68 to +78°, c = 1 in chloroform-d |
| InChIKey | WOXKDUGGOYFFRN-IIBYNOLFSA-N |
| CAS DataBase Reference | 171596-29-5(CAS DataBase Reference) |
